Insights On Upstream Manufacturing
-
Discover The Benchtop DynaDrive Single-Use Bioreactor
8/20/2025
Ready to transform your process development? Introducing the 5 L Thermo Scientific DynaDrive Single‑Use Bioreactor (S.U.B.), now available! Experience the same bioreactor design from bench to commercial and re‑imagine scalability in process development.
-
Optimizing VLP Manufacturing For Gene Editing By GMP-Compliant Flow Electroporation®
8/20/2025
Learn how a novel approach to VLP manufacturing can overcome common scalability and consistency issues, enabling high yields and potent gene editing in a single day.
-
Scalable Electroporation Optimizes Transposon Delivery In CAR T Cell Manufacturing Workflows
8/20/2025
Learn how electroporation can be used to efficiently engineer T cells for CAR T cell manufacturing workflows with piggyBac™ transposons while maintaining high viability and cell yield.
-
Time To Intensify: Taking mAb Manufacturing To The Next Level
8/19/2025
Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.
-
Cell Line Development For Bispecific Antibodies
8/18/2025
See how the recently described cell line development paradigm shift, enabled by the Leap-In transposon platform, can extend to the development of bispecific monoclonal antibody-producing cell substrates.
-
Keys To Achieving Unparalleled Flexibility In CHO Based Bioproduction
8/16/2025
The dynamic growth and pace of change observed in novel mAb formats and cell and gene therapies emphasizes that biomanufacturing innovation is essential to deliver scale, speed, and sustainability.
-
Building A Biomanufacturing Ecosystem For Supply Agility Starts Early
8/16/2025
Unprecedented capital investments of >$8bn expand capacity to improve patient access. Going beyond expansions, learn more about a holistic, globally harmonized operational ecosystem.
-
Accelerate Your Path To The Clinic: Custom Cell Culture Media Solutions
8/15/2025
A strategic approach to cell culture media is essential for success. Learn how to get a head start toward clinical readiness and avoid future hurdles with optimized media.
-
An Alternative Genetic Engineering Tool In CHO Cells
8/15/2025
Discover how transposon technology is being reimagined as a precise genetic engineering tool to create high-performing CHO cell lines for biotherapeutic production with enhanced metabolic and glycan profiles.
-
Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.
8/12/2025
On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.